DUBLIN, March 17, 2020 /PRNewswire/ -- The "Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application ...

PoC testing is in the market today – it is worth approximately US$11.5 billion annually, with percentage growth in double figures and some three-times faster than the total IVD market. Applications to ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

The point of care molecular (POC) diagnostics market is poised for robust growth on the back of the burgeoning prevalence of infectious diseases across the globe. As per the CDC (Centers for Disease ...

The MarketWatch News Department was not involved in the creation of this content. The Point-of-Care Diagnostics market is driven by the increasing demand for rapid and accurate testing solutions, ...

Abbott Laboratories holds a leadership position in the point of care diagnostics market through its diverse range of products including glucose monitoring devices, infectious disease diagnostic tools, ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

Study of the evolution of PoC testing shows that technology development has progressed to be close to laboratory quality and to meet the clinical needs. In the past, simple chemical test methods were ...